Pathophysiology and epidemiology of hemophagocytic lymphohistiocytosis
Open Access
- 5 December 2015
- journal article
- review article
- Published by American Society of Hematology in Hematology-American Society Hematology Education Program
- Vol. 2015 (1) , 177-182
Abstract
Hemophagocytic lymphohistiocytosis (HLH) is a syndrome characterized by extreme immune activation, resulting in pathologic inflammation. The diagnosis includes a spectrum of inherited or acquired defects in cytotoxic lymphocyte function, often with uncontrolled infections. HLH may also arise as the result of persistent antigen stimulation due to autoimmune disease or malignancy. HLH is often described in binary terms as “primary,” indicating Mendelian inheritance of gene mutations resulting in cytotoxic lymphocyte dysfunction, or “secondary” indicating an acquired reactive disorder. Increasing evidence describes HLH as more complex phenomenon, resulting from specific immune challenges in patients with a susceptible genetic background. Early recognition of HLH and evaluation of potential causes is critically important, as survival generally requires urgent treatment with immune suppression and resolution of the activating antigen. However, the diagnosis of HLH is challenged by the myriad of pathways that lead to pathologic inflammation and the clinical overlap with other conditions. Further improvements in therapy will require prospective trials to define optimal strategies for each patient based on the individual paths that lead to pathologic inflammation.Keywords
This publication has 46 references indexed in Scilit:
- Hemophagocytic syndromes — An updateBlood Reviews, 2014
- Adult haemophagocytic syndromeThe Lancet, 2014
- Hemophagocytic Lymphohistiocytosis: Advances in Pathophysiology, Diagnosis, and TreatmentThe Journal of Pediatrics, 2013
- How I treat hemophagocytic lymphohistiocytosisBlood, 2011
- HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosisPediatric Blood & Cancer, 2006
- Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: molecular and functional analyses ofPRF1, UNC13D, STX11, andRAB27AHuman Mutation, 2005
- Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantationBlood, 2002
- Linkage of Familial Hemophagocytic Lymphohistiocytosis to 10q21-22 and Evidence for HeterogeneityThe American Journal of Human Genetics, 1999
- Familial hemophagocytic lymphohistiocytosisEuropean Journal of Pediatrics, 1983
- Familial Haemophagocytic ReticulosisArchives of Disease in Childhood, 1952